{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:27:49Z","timestamp":1761863269696,"version":"3.40.4"},"reference-count":39,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.4155\/bio.13.278","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T08:58:37Z","timestamp":1387270717000},"page":"21-32","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["PK of Immunoconjugate Anticancer Agent Cmd-193 in Rats: Ligand-Binding Assay Approach to Determine<i>In Vivo<\/i>Immunoconjugate Stability"],"prefix":"10.1080","volume":"6","author":[{"given":"Azher","family":"Hussain","sequence":"first","affiliation":[{"name":"Pharmacokinetic, Pharmacodynamics &amp; Drug Metabolism, Merck Sharp &amp; Dohme Corp., West Point, Pennsylvania, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Gorovits","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics, Dynamics &amp; Metabolism, Pfizer Inc, Andover, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Leal","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics, Dynamics &amp; Metabolism, Pfizer Inc., Pearl River, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Fluhler","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics, Dynamics &amp; Metabolism, Pfizer Inc., Pearl River, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,12,17]]},"reference":[{"key":"e_1_3_4_2_1_1","first-page":"404","volume-title":"Collected Studies in Immunity","author":"Ehlrich P","year":"1906","unstructured":"Ehlrich P . The relations existing between chemical constitution, distribution, and pharmacological action. In: Collected Studies in Immunity. Ehlrich P (Ed.). John Wiley & Sons, NY, USA, 404\u2013442 (1906)."},{"issue":"6","key":"e_1_3_4_2_2_1","first-page":"1490","article-title":"Approval summary: gemtuzumabozogamicin in relapsed acute myeloid leukemia","volume":"7","author":"Bross PF","year":"2001","unstructured":"Bross PF , BeitzJ, ChenGet al. Approval summary: gemtuzumabozogamicin in relapsed acute myeloid leukemia. Clin. Cancer Res. 7(6), 1490\u20131496 (2001).","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"e_1_3_4_2_3_1","first-page":"44","article-title":"Recombinant toxins for the treatment of cancer","volume":"5","author":"Kreitman RJ","year":"2003","unstructured":"Kreitman RJ . Recombinant toxins for the treatment of cancer. Curr. Opin. Mol. Ther. 5(1), 44\u201351 (2003).","journal-title":"Curr. Opin. Mol. Ther"},{"key":"e_1_3_4_2_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.23803"},{"key":"e_1_3_4_2_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2003.10.002"},{"key":"e_1_3_4_2_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3629"},{"key":"e_1_3_4_2_7_1","doi-asserted-by":"publisher","DOI":"10.2146\/news130023"},{"key":"e_1_3_4_2_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e318172d704"},{"key":"e_1_3_4_2_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzl013"},{"key":"e_1_3_4_2_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-1776"},{"key":"e_1_3_4_2_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1905"},{"key":"e_1_3_4_2_12_1","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.2001.6305"},{"key":"e_1_3_4_2_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0037"},{"key":"e_1_3_4_2_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.16.8618"},{"issue":"9","key":"e_1_3_4_2_15_1","first-page":"2546","article-title":"Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate","volume":"62","author":"Ross S","year":"2002","unstructured":"Ross S , SpencerSD, HolcombIet al. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res. 62(9), 2546\u20132553 (2002).","journal-title":"Cancer Res"},{"key":"e_1_3_4_2_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt832"},{"key":"e_1_3_4_2_17_1","doi-asserted-by":"publisher","DOI":"10.2174\/156800909790192365"},{"key":"e_1_3_4_2_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1417"},{"key":"e_1_3_4_2_19_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2011.582866"},{"key":"e_1_3_4_2_20_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2011.539557"},{"key":"e_1_3_4_2_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<50::AID-IJC9>3.0.CO;2-0"},{"issue":"7","key":"e_1_3_4_2_22_1","first-page":"2183","article-title":"Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens","volume":"50","author":"Hellstrom I","year":"1990","unstructured":"Hellstrom I , GarriguesHJ, GarriguesU, HellstromKE. Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. Cancer Res. 50(7), 2183\u20132190 (1990).","journal-title":"Cancer Res"},{"issue":"12","key":"e_1_3_4_2_23_1","first-page":"3254","article-title":"Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors","volume":"60","author":"Scott AM","year":"2000","unstructured":"Scott AM , GeleickD, RubiraMet al. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors. Cancer Res. 60(12), 3254\u20133261 (2000).","journal-title":"Cancer Res"},{"issue":"2","key":"e_1_3_4_2_24_1","first-page":"607","article-title":"Ley specific antibody with potent anti-tumor activity is internalized and degraded in lysosomes","volume":"142","author":"Garrigues J","year":"1993","unstructured":"Garrigues J , GarriguesU, HellstromI, HellstromKE. Ley specific antibody with potent anti-tumor activity is internalized and degraded in lysosomes. Am. J. Pathol. 142(2), 607\u2013622 (1993).","journal-title":"Am. J. Pathol"},{"key":"e_1_3_4_2_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.26.12957"},{"key":"e_1_3_4_2_26_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAM.0000003390.51761.3d"},{"key":"e_1_3_4_2_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.7211"},{"key":"e_1_3_4_2_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc200212a"},{"key":"e_1_3_4_2_29_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2011.641532"},{"issue":"1","key":"e_1_3_4_2_30_1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0022-3565(24)37962-5","article-title":"Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor","volume":"288","author":"Lin YS","year":"1999","unstructured":"Lin YS , NguyenC, MendozaJLet al. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor. J. Pharmacol. Exp. Ther. 288(1), 371\u2013378 (1999).","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_3_4_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2008.06.012"},{"key":"e_1_3_4_2_32_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.060533"},{"key":"e_1_3_4_2_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.843.11.2"},{"key":"e_1_3_4_2_34_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.11.30"},{"key":"e_1_3_4_2_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0789"},{"key":"e_1_3_4_2_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc800059t"},{"key":"e_1_3_4_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2011.01.004"},{"key":"e_1_3_4_2_38_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.13.66"},{"key":"e_1_3_4_3_2_1","unstructured":"Guide for the Care and Use of Laboratory Animals (Eighth Edition). www.nap.edu\/catalog\/12910.html"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/bio.13.278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T06:15:16Z","timestamp":1746080116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/bio.13.278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,17]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.4155\/bio.13.278"],"URL":"https:\/\/doi.org\/10.4155\/bio.13.278","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"type":"print","value":"1757-6180"},{"type":"electronic","value":"1757-6199"}],"subject":[],"published":{"date-parts":[[2013,12,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2013-12-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}